Found: 7
Select item for more details and to access through your institution.
Growth hormone (GH) rebound rise following somatostatin infusion withdrawal: studies in dogs with the use of GH-releasing hormone and a GH-releasing peptide.
- Published in:
- European Journal of Endocrinology, 2001, v. 145, n. 5, p. 635, doi. 10.1530/eje.0.1450635
- By:
- Publication type:
- Article
Orexigenic Effects of a Growth Hormone Secretagogue and Nitric Oxide in Aged Rats and Dogs: Correlation With the Hypothalamic Expression of Some Neuropeptidergic/Receptorial Effectors Mediating Food Intake.
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2006, v. 61, n. 4, p. 315, doi. 10.1093/gerona/61.4.315
- By:
- Publication type:
- Article
GSK3A Is Redundant with GSK3B in Modulating Drug Resistance and Chemotherapy-Induced Necroptosis.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0100947
- By:
- Publication type:
- Article
BTK inhibitors synergise with 5‐FU to treat drug‐resistant TP53‐null colon cancers.
- Published in:
- Journal of Pathology, 2020, v. 250, n. 2, p. 134, doi. 10.1002/path.5347
- By:
- Publication type:
- Article
Severely Obese Adolescents and Adults Exhibit a Different Association of Circulating Levels of Adipokines and Leukocyte Expression of the Related Receptors with Insulin Resistance.
- Published in:
- International Journal of Endocrinology, 2013, p. 1, doi. 10.1155/2013/565967
- By:
- Publication type:
- Article
Testosterone Inhibition of Growth Hormone Release Stimulated by a Growth Hormone Secretagogue.
- Published in:
- Neuroendocrinology, 2006, v. 84, n. 2, p. 115, doi. 10.1159/000096998
- By:
- Publication type:
- Article
p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1199-7
- By:
- Publication type:
- Article